HomeCompareYLDGF vs ABBV

YLDGF vs ABBV: Dividend Comparison 2026

YLDGF yields 381.10% · ABBV yields 3.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 YLDGF wins by $89.4K in total portfolio value
10 years
YLDGF
YLDGF
● Live price
381.10%
Share price
$0.52
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$191.8K
Annual income
$362.09
Full YLDGF calculator →
ABBV
AbbVie Inc.
● Live price
3.06%
Share price
$217.44
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.3K
Annual income
$24,771.77
Full ABBV calculator →

Portfolio growth — YLDGF vs ABBV

📍 YLDGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodYLDGFABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, YLDGF + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
YLDGF pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

YLDGF
Annual income on $10K today (after 15% tax)
$32,393.29/yr
After 10yr DRIP, annual income (after tax)
$307.78/yr
ABBV
Annual income on $10K today (after 15% tax)
$259.96/yr
After 10yr DRIP, annual income (after tax)
$21,056.00/yr
At 15% tax rate, ABBV beats the other by $20,748.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of YLDGF + ABBV for your $10,000?

YLDGF: 50%ABBV: 50%
100% ABBV50/50100% YLDGF
Portfolio after 10yr
$147.0K
Annual income
$12,566.93/yr
Blended yield
8.55%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

YLDGF
No analyst data
Altman Z
0.9
Piotroski
5/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+17.8% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

YLDGF buys
0
ABBV buys
0
No recent congressional trades found for YLDGF or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricYLDGFABBV
Forward yield381.10%3.06%
Annual dividend / share$2.00$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%40.6%
Portfolio after 10y$191.8K$102.3K
Annual income after 10y$362.09$24,771.77
Total dividends collected$107.4K$61.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: YLDGF vs ABBV ($10,000, DRIP)

YearYLDGF PortfolioYLDGF Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$29,755$19,054.88$11,550$430.00+$18.2KYLDGF
2$58,332$26,494.19$13,472$627.96+$44.9KYLDGF
3$86,686$24,270.84$15,906$926.08+$70.8KYLDGF
4$109,608$16,854.42$19,071$1,382.55+$90.5KYLDGF
5$127,240$9,958.52$23,302$2,095.81+$103.9KYLDGF
6$141,548$5,402.06$29,150$3,237.93+$112.4KYLDGF
7$154,265$2,808.20$37,536$5,121.41+$116.7KYLDGF
8$166,494$1,430.13$50,079$8,338.38+$116.4KYLDGF
9$178,869$721.26$69,753$14,065.80+$109.1KYLDGF
10$191,752$362.09$102,337$24,771.77+$89.4KYLDGF

YLDGF vs ABBV: Complete Analysis 2026

YLDGFStock

Yanlord Land Group Limited, an investment holding company, operates as a real estate developer in the People's Republic of China, Singapore, and Hong Kong. The company operates through Property Development, Property Investment and Hotel Operations, Property Management, and Others segments. It develops residential properties, including apartment complexes and villas; and commercial and integrated properties, such as offices, retail shopping centers, serviced apartments, hotels, recreation facilities, and business parks, as well as offers property management services for residential and commercial properties. In addition, the company is involved in the leasing of properties and operation of hotels; hotels and serviced apartment management; trading of building materials and hardware; installation, maintenance, sale, and repair of elevators; project and business management; agribusiness exhibition and trade emporium center; manufacture of electronic components and connectors; die casting and precision engineering; mineral sand mining; transplant technology; and production of seedlings and bio-electronic products. Further, the company provides landscaping and gardening, investment management, city redevelopment, food and beverage, leisure and fitness, tourism investment, asset management, information technology, education and training, cultural and art performance, construction engineering, tourism and travel, and financial services. Additionally, it is involved in the civil, electrical, and mechanical engineering and contract businesses; supply, delivery, testing, and commissioning of telecommunication equipment and after-sales service; and supply and installation of building materials, industrial laundry, and automotive parts and equipment. Yanlord Land Group Limited was founded in 1993 and is based in Singapore.

Full YLDGF Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this YLDGF vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

YLDGF vs SCHDYLDGF vs JEPIYLDGF vs OYLDGF vs KOYLDGF vs MAINYLDGF vs JNJYLDGF vs MRKYLDGF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.